Clinical trial
Prognostic Molecular and Environmental Factors in High-Risk Stage II and Stage III Colon Cancer Patients
NCT00354705 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prognostic Molecular and Environmental Factors in High-Risk Stage II and Stage III Colon Cancer Patients
- Lead sponsor
- M.D. Anderson Cancer Center
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- January 31, 2006
- Completion date
- January 31, 2020
- Enrollment
- 200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
colon cancer